Investigation of the immunocompetent cells that bind early pregnancy factor and preliminary studies of the early pregnancy factor target molecule

Immunology and Cell Biology

Volumn 82, Issue 4, 2004, Pages 361-369

  Athanasas Platsis, Stavrosia ^a   Somodevilla Torres, Maria J ^a   Morton, Halle ^a   Cavanagh, Alice C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chaperonin 10; Early pregnancy factor; Early pregnancy factor receptor; Lymphocyte; Monocyte

Indexed keywords

CD14 ANTIGEN; CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHAPERONIN; EARLY PREGNANCY FACTOR; EARLY PREGNANCY FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; CROSS LINKING; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PROTEIN BINDING; PROTEIN FUNCTION; SPLEEN CELL;

ANIMALS; ANTIGENS, CD14; ANTIGENS, CD56; ANTIGENS, CD8; CHAPERONIN 60; FEMALE; HUMANS; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MALE; MICE; MONOCYTES; PEPTIDES; PREGNANCY; PREGNANCY PROTEINS; RATS; ROSETTE FORMATION; SUPPRESSOR FACTORS, IMMUNOLOGIC;

ANIMALIA;

EID: 4344629738     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01260.x     Document Type: Article

References (45)

1. Morton H, Hegh V, Clunie GJA. Immunosuppression detected in pregnant mice by rosette inhibition test. Nature 1974; 249: 459-60.
2. Morton H, Hegh V, Clunie GJA. Studies of the rosette inhibition test in pregnant mice: evidence of immunosuppression? Proc. R. Soc. B. 1976; 193: 413-19.
3. Morton H, Rolfe BE, Cavanagh AC. Ovum factor and early pregnancy factor. Curr. Top. Dev. Biol. 1987; 23: 73-92.
4. Athanasas S, Quinn KA, Wong T-Y, Rolfe BE, Cavanagh AC, Morton H. Passive immunisation of pregnant mice against early pregnancy factor (EPF) causes loss of embryonic viability. J. Reprod. Fertil. 1989; 87: 495-502.
5. Athanasas-Platsis S, Morton H, Dunglison GF, Kaye PL. Antibodies to early pregnancy factor retard embryonic development in vitro. J. Reprod. Fertil. 1991; 92: 443-51.
6. Athanasas-Platsis S, Corcoran CM, Kaye PL, Cavanagh AC, Morton H. Early pregnancy factor is required at two important stages of embryonic development in the mouse. Am. J. Reprod. Immunol. 2000; 43: 223-30.
7. Quinn KA, Athanasas-Platsis S, Wong T-Y, Rolfe BE, Cavanagh AC, Morton H. Monoclonal antibodies to early pregnancy factor perturb tumour cell growth. Clin. Exp. Immunol. 1990; 80: 100-8.
8. Quinn KA, Cavanagh AC, Hillyard NC, McKay DA, Morton H. Early pregnancy factor (EPF) in liver regeneration after partial hepatectomy in rats: its relationship to chaperonin 10. Hepatology 1994; 20: 1294-302.
9. Quinn KA, Morton H. Effect of anti-EPF monoclonal antibodies on the in vivo growth of transplanted murine tumours. Cancer Immunol. Immunother. 1992; 34: 265-71.
10. Morton H. Early pregnancy factor: an extracellular chaperonin 10 homologue. Immunol. Cell Biol. 1998; 76: 483-96.
11. Zhang B, Harness J, Somodevilla-Torres MJ et al. Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151. J. Neurol. Sci. 2000; 182: 5-15.
12. Noonan FP, Halliday WJ, Morton H, Clunie GJA. Early pregnancy factor is immunosuppressive. Nature 1979; 278: 649-51.
13. Zhang B, Walsh MD, Nguyen KB, Hillyard NC, Cavanagh AC, Morton H. Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobenzene in normal BALB/c mice. J. Neurol. Sci. 2003; 212: 37-46.
14. Morton H, McKay DA, Murphy RM et al. Production of a recombinant form of early pregnancy factor that can prolong allogeneic skin survival time in rats. Immunol. Cell Biol. 2000; 78: 603-7.
15. Rolfe BE, Cavanagh AC, Quinn KA, Morton H. Identification of two suppressor factors induced by early pregnancy factor. Clin. Exp. Immunol. 1988; 73: 219-25.
16. Rolfe BE, Quinn KA, Athanasas-Platsis S, Cavanagh AC, Morton H. Genetically-restricted effector molecules released by human lymphocytes in response to early pregnancy factor. Immunol. Cell Biol. 1989; 67: 205-8.
17. Cavanagh AC, Morton H. The purification of early pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur. J. Biochem. 1994; 222: 551-60.
18. Hartmann DJ, Hoogenraad NJ, Condron R, Hφj PB. Identification of a mammalian 10-kDa heat shock protein, a mitochondrial chaperonin 10 homologue essential for assisted folding of trimeric ornithine transcarbamoylase in vitro. Proc. Natl Acad. Sci. USA 1992; 89: 3394-8.
19. Lindquist S, Craig EA. The heat shock proteins. Annu. Rev. Genet. 1988; 22: 631-77.
20. Ellis RJ, van der Vies SM. Molecular chaperones. Annu. Rev. Biochem. 1991; 60: 321-47.
21. Summers KM, Murphy RM, Webb GC et al. The human early pregnancy factor/chaperonin 10 gene family. Biochem. Mol. Med. 1996; 58: 52-8.
22. Martin J, Mayhew M, Langer T, Hartl FU. The reaction cycle of GroEL and GroES in chaperonin-assisted protein folding. Nature 1993; 366: 228-33.
23. Brudzynski K, Martinez V, Gupta RS. Immunocytochemical localization of heat-shock protein 60-related protein in Beta-cell secretory granules and its altered distribution in non-obese diabetic mice. Diabetologia 1992; 35: 316-24.
24. Kaur I, Voss SD, Gupta RS, Schell K, Fisch P, Sondel PM. Human peripheral γδ T cells recognise hsp60 molecules on Daudi Burkitt's lymphoma cells. J. Immunol. 1993; 150: 2046-55.
25. Love SG, Engelbretsen DR, Garnham B et al. Observation of protein heptamer formation for chemically ligated early pregnancy factor. In: Ens W, Standing KG, Chernushevich IV (eds). New Methods for the Study of Biomolecular Complexes, NATO ASI Series. Series C: Mathematical and Physical Sciences, Vol. 510. The Netherlands: Kluwer Academic Publishers, 1998; 171-9.
26. Cavanagh AC, Morton H. EPF: embryo detector and molecular chaperone. Tod. Life Sci. 1996; 8: 24-7.
27. Rolfe BE, Cavanagh AC, Forde C, Bastin F, Chen C, Morton H. Modified rosette inhibition test with mouse lymphocytes for detection of early pregnancy factor in human pregnancy serum. J. Immunol. Methods 1984; 70: 1-11.
28. Cruz YP, Selwood L, Morton H, Cavanagh AC. Significance of serum early pregnancy factor concentrations during pregnancy and embryonic development in Sminthopsis macroura (Spencer) (Marsupialia: Dasyuridae). Reproduction 2001; 121: 933-9.
29. Somodevilla-Torres MJ, Hillyard NC, Morton H et al. Preparation and characterization of polyclonal antibodies against human chaperonin 10. Cell Stress Chaperones 2000; 5: 14-20.
30. Ryan MT, Naylor DJ, Hoogenraad NJ, Hoj PB. Affinity purification, overexpression and characterization of Chaperonin 10 homologues synthesized with and without N-terminal acetylation. J. Biol. Chem. 1995; 270: 22 037-43.
31. Piccinni MP. Role of immune cells in pregnancy. Autoimmunity 2003; 36: 1-4.
32. Quenby S, Bates M, Doig T et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum. Reprod. 1999; 14: 2386-91.
33. Kreiger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J. Exp. Med. 1996; 184: 2013-18.
34. Hamann D, Baars PA, Hooibrink B, van Lier RW. Heterogeneity of the human CD4+ T-cell subsets characterised by coexpression of CD45 CD45RO isoforms. Blood 1996; 88: 3513-21.
35. Prince HE, York J, Jensen ER. Phenotypic comparison of three populations of human lymphocytes defined by CD45RO and CD45RA expression. Cell Immunol. 1992; 145: 254-62.
36. Zola H, Flego L, Macardle PJ, Donohue PJ, Ranford J, Roberton D. The CD45RO (p180, UCHL1) marker: Complexity of expression in peripheral blood. Cell Immunol. 1992; 145: 175-86.
37. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995; 155: 1151-64.
38. Kohm AP, Carpentier PA, Anger HA, Miller SD. CD4+ CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 2002; 169: 4712-16.
39. Athanasas-Platsis S, Zhang B, Hillyard NC et al. Early pregnancy factor suppresses the infiltration of lymphocytes and macrophages in the spinal cord of rats during experimental autoimmune encephalomyelitis but has no effect on apoptosis. J. Neurol. Sci. 2003; 214: 27-36.
40. Hintzen RO, de Jong R, Lens SM, Brouwer M, Baars P, van Lier RA. Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 1993; 151: 2426-35.
41. Izikson L, Klein RS, Luster AD, Weiner HL. Targeting monocyte recruitment in CNS autoimmune disease. Clin. Immunol. 2002; 103: 125-31.
42. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem. Immunol. 1999; 72: 7-29.
43. Naquet P, Pierres M. Cell surface enzymes and lymphocyte functions. Curr. Opin. Immunol. 1991; 3: 326-9.
44. Chen WT. Membrane proteases: roles in tissue remodeling and tumour invasion. Curr. Opin. Cell Biol. 1992; 4: 802-9.
45. Konkoy CS, Davis TP. Ectoenzymes as sites of peptide regulation. Trends Pharmacol. Sci. 1996; 17: 288-94.